{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:47:17Z","timestamp":1769510837647,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.neulet.2010.01.010","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T05:57:33Z","timestamp":1263880653000},"page":"53-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway"],"prefix":"10.1016","volume":"471","author":[{"given":"Daisuke","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Kanahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Sutoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2010.01.010_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0091-3057(00)00409-3","article-title":"Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats","volume":"67","author":"Bast","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2010.01.010_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(00)00139-0","article-title":"Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia","volume":"49","author":"Braff","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2010.01.010_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopsych.2004.12.002","article-title":"Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions","volume":"57","author":"Browning","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pbb.2005.01.012","article-title":"The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating","volume":"80","author":"Buben\u00edkov\u00e1","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2010.01.010_bib5","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0091-3057(95)02096-9","article-title":"Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats","volume":"53","author":"Fujikawa","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2010.01.010_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2010.01.010_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.mp.4001159","article-title":"Mouse genetic models for prepulse inhibition: an early review","volume":"7","author":"Geyer","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/FBP.0b013e32830cd822","article-title":"Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology","volume":"19","author":"Gogos","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neulet.2010.01.010_bib11","first-page":"147","article-title":"Glutamate hypothesis of schizophrenia and approach for possible therapeutic drugs","volume":"4","author":"Hashimoto","year":"2004","journal-title":"Curr. Med. Chem. CNS Agents"},{"key":"10.1016\/j.neulet.2010.01.010_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-008-1151-6","article-title":"Glycine and d-serine, but not d-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801","volume":"198","author":"Kanahara","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2010.01.010_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/eoid.12.4.655.23750","article-title":"Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic","volume":"12","author":"Keck","year":"2003","journal-title":"Expert. Opin. Invest. Drugs"},{"key":"10.1016\/j.neulet.2010.01.010_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","article-title":"7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity","volume":"274","author":"Kikuchi","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2010.01.010_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2010.01.010_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-005-2210-x","article-title":"Modulators of the glycine site on NMDA receptors. d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia","volume":"179","author":"Lipina","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2010.01.010_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00207450601041989","article-title":"The effect of aripiprazole on prepulse inhibition of the startle response in normal and hyperdopaminergic states in rats","volume":"118","author":"Nakai","year":"2008","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neulet.2010.01.010_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2007.10.010","article-title":"Effects of aripiprazole\/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats","volume":"54","author":"Nordquist","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2010.01.010_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0893-133X(95)00079-S","article-title":"NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia","volume":"13","author":"Olney","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2010.01.010_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2010.01.010_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lfs.2008.05.014","article-title":"Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area","volume":"83","author":"Schwieler","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2010.01.010_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib24","doi-asserted-by":"crossref","first-page":"28325","DOI":"10.1074\/jbc.270.47.28325","article-title":"Differential activation of mitogen-activated protein kinase and S6 kinase signaling pathways by 12-O-tetradecanoylphorbol-13-acetate (TPA) and insulin. Evidence for involvement of a TPA-stimulated protein-tyrosine kinase","volume":"270","author":"Seger","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2010.01.010_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2010.01.010_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v62n1101","article-title":"Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, \u201cGoldilocks\u201d actions at dopamine receptors","volume":"62","author":"Stahl","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0006-3223(86)90005-3","article-title":"Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics","volume":"21","author":"Swerdlow","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","article-title":"Assessing the validity of an animal model of deficient sensorymotor gating in schizophrenia patients","volume":"51","author":"Swerdlow","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2010.01.010_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","article-title":"Using an animal model of deficient sensorigating to study the pathophysiology and new treatments of schizophrenia","volume":"24","author":"Swerdlow","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2010.01.010_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1301071","article-title":"Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways","volume":"32","author":"Urban","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2010.01.010_bib31","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0006-3223(98)00356-4","article-title":"Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats","volume":"46","author":"Yamada","year":"1999","journal-title":"Biol. Psychiatry"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:10:29Z","timestamp":1759608629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394010000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0304394010000261"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2010.01.010","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2010.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}